A recent study published in Nature has revealed that elevated perimenopausal FSH levels are associated with the risk of AD, as higher FSH levels accelerate the deposition of Aβ peptides and tau protein in the brain [47]. This evidence concerns the gene MAPT and Alzheimer disease.